EIG
ABBV icon

Ellenbecker Investment Group’s AbbVie ABBV Stock Holding History

Ellenbecker Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.28M Buy
5,888
+279
+5% +$61.9K 0.17% 36
2025
Q4 		$1.28M Buy
5,609
+275
+5% +$62.6K 0.18% 35
2025
Q3 		$1.24M Buy
5,334
+44
+0.8% +$8.96K 0.18% 37
2025
Q2 		$982K Buy
5,290
+7
+0.1% +$1.3K 0.16% 40
2025
Q1 		$1.11M Buy
5,283
+627
+13% +$122K 0.2% 38
2024
Q4 		$827K Sell
4,656
-730
-14% -$134K 0.15% 49
2024
Q3 		$1.06M Sell
5,386
-675
-11% -$126K 0.2% 42
2024
Q2 		$1.04M Buy
6,061
+82
+1% +$13.6K 0.21% 39
2024
Q1 		$1.09M Buy
5,979
+95
+2% +$16.4K 0.23% 38
2023
Q4 		$911K Buy
5,884
+153
+3% +$22.3K 0.21% 42
2023
Q3 		$854K Sell
5,731
-72
-1% -$10.6K 0.22% 40
2023
Q2 		$781K Buy
5,803
+83
+1% +$12.2K 0.2% 43
2023
Q1 		$911K Buy
5,720
+42
+0.7% +$6.42K 0.25% 35
2022
Q4 		$917K Buy
5,678
+718
+14% +$110K 0.27% 34
2022
Q3 		$665K Buy
4,960
+286
+6% +$41K 0.21% 35
2022
Q2 		$715K Buy
4,674
+132
+3% +$20.2K 0.22% 34
2022
Q1 		$736K Buy
4,542
+33
+0.7% +$4.79K 0.21% 36
2021
Q4 		$610K Buy
4,509
+45
+1% +$5.32K 0.17% 36
2021
Q3 		$481K Sell
4,464
-35
-0.8% -$4K 0.15% 39
2021
Q2 		$507K Sell
4,499
-31
-0.7% -$3.49K 0.17% 34
2021
Q1 		$490K Buy
4,530
+93
+2% +$9.95K 0.17% 38
2020
Q4 		$475K Buy
4,437
+8
+0.2% +$769 0.18% 38
2020
Q3 		$388K Buy
4,429
+72
+2% +$6.78K 0.17% 41
2020
Q2 		$428K Buy
4,357
+171
+4% +$15.1K 0.21% 34
2020
Q1 		$319K Buy
4,186
+5
+0.1% +$426 0.2% 37
2019
Q4 		$370K Sell
4,181
-98
-2% -$8.14K 0.19% 39
2019
Q3 		$324K Buy
4,279
+283
+7% +$19.4K 0.18% 43
2019
Q2 		$291K Buy
3,996
+348
+10% +$27.4K 0.17% 45
2019
Q1 		$294K Buy
3,648
+243
+7% +$19.9K 0.19% 47
2018
Q4 		$314K Buy
+3,405
New +$299K 0.24% 40

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ellenbecker Investment Group's ABBV Position: Q1 2026 in Review

Ellenbecker Investment Group increased its AbbVie (ABBV) stake by 5% in Q1 2026, buying an estimated $61.9K and bringing the position to 5,888 shares worth $1.28M. The position accounts for 0.17% of the portfolio, ranked #36.

Ellenbecker Investment Group first reported a position in ABBV in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.28M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Ellenbecker Investment Group held 5,888 shares of AbbVie worth $1.28M as of Q1 2026.
  • Ellenbecker Investment Group bought 279 AbbVie shares in Q1 2026, an estimated $61.9K.
  • AbbVie made up 0.17% of Ellenbecker Investment Group's portfolio in Q1 2026, its #36 holding.
  • Ellenbecker Investment Group first reported a position in AbbVie in Q4 2018 and has held it in 30 quarters since.
  • Ellenbecker Investment Group's AbbVie position peaked at $1.28M in Q4 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Ellenbecker Investment Group's 13F filing for Q1 2026, filed 23 Apr 2026.